Archived Clinical Summary
Depression in Children and Adolescents: Screening
Originally published on: January 9, 2014
This recommendation statement is currently archived and inactive. It should be used for historical purposes only. Click here for copyright and source information .
Disclaimer:Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Archived: Clinical Summary of U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2009 recommendation of the U.S. Preventive Services Task Force (USPSTF) on screening and treatment for major depressive disorder in children and adolescents. This summary is intended for use by primary care clinicians.
|Population||Adolescents (12-18 years)||Children (7-11 years)|
|Recommendation||Screen (when systems for diagnosis, treatment, and follow-up are in place)||No Recommendation|
Risk factors for major depressive disorder (MDD) include parental depression, having comorbid mental health or chronic medical conditions, and having experienced a major negative life event.
The following screening tests have been shown to do well in teens in primary care settings:
Screening instruments perform less well in younger children.
Among pharmacotherapies fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has been found efficacious. However, because of risk of suicidality, SSRIs should be considered only if clinical monitoring is possible. Various modes of psychotherapy, and pharmacotherapy combined with psychotherapy, have been found efficacious.
Evidence on the balance of benefits and harms of treatment of younger children is insufficient for a recommendation.
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents, please go to: http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Copyright and Source Information
This document is in the public domain within the United States.
Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.
Internet Citation: Clinical Summary: Depression in Children and Adolescents: Screening. U.S. Preventive Services Task Force. February 2014.